| A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans L Prokunina, C Castillejo-López, F Öberg, I Gunnarsson, L Berg, ... Nature genetics 32 (4), 666-669, 2002 | 1001 | 2002 |
| Autoantibody profiles in the sera of European patients with myositis R Brouwer, GJD Hengstman, WV Egberts, H Ehrfeld, B Bozic, ... Annals of the rheumatic diseases 60 (2), 116-123, 2001 | 508 | 2001 |
| Inequities in access to biologic and synthetic DMARDs across 46 European countries P Putrik, S Ramiro, TK Kvien, T Sokka, M Pavlova, T Uhlig, A Boonen, ... Annals of the rheumatic diseases 73 (1), 198-206, 2014 | 387 | 2014 |
| Cytokine production, serum levels and disease activity in systemic lupus erythematosus G Grondal, I Gunnarsson, J Ronnelid, S Rogberg, L Klareskog, ... Clinical and experimental rheumatology 18 (5), 565-570, 2000 | 381 | 2000 |
| A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q AKB Lindqvist, K Steinsson, B Johanneson, H Kristjansdottir, A Àrnasson, ... Journal of autoimmunity 14 (2), 169-178, 2000 | 244 | 2000 |
| The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient GJD Hengstman, WJ Van Venrooij, J Vencovsky, HM Moutsopoulos, ... Annals of the rheumatic diseases 59 (2), 141-142, 2000 | 162 | 2000 |
| Risk of drug-induced liver injury from tumor necrosis factor antagonists ES Björnsson, BI Gunnarsson, G Gröndal, JG Jonasson, R Einarsdottir, ... Clinical Gastroenterology and Hepatology 13 (3), 602-608, 2015 | 136 | 2015 |
| Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth? P Putrik, S Ramiro, TK Kvien, T Sokka, T Uhlig, A Boonen, ... Annals of the rheumatic diseases 73 (11), 2010-2021, 2014 | 122 | 2014 |
| FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease S Saevarsdottir, TA Olafsdottir, EV Ivarsdottir, GH Halldorsson, ... Nature 584 (7822), 619-623, 2020 | 103 | 2020 |
| Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial ML Hetland, EA Haavardsholm, A Rudin, D Nordström, M Nurmohamed, ... bmj 371, 2020 | 98 | 2020 |
| Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study R Knevel, G Gröndal, TWJ Huizinga, AW Visser, H Jónsson, A Víkingsson, ... Annals of the rheumatic diseases 71 (5), 707-709, 2012 | 88 | 2012 |
| Increased number of interleukin‐10–producing cells in systemic lupus erythematosus patients and their first‐degree relatives and spouses in Icelandic multicase families G Gröndal, H Kristjansdottir, B Gunnlaugsdottir, A Arnason, I Lundberg, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 86 | 1999 |
| Lower expression levels of the programmed death 1 receptor on CD4+ CD25+ T cells and correlation with the PD‐1.3 A genotype in patients with systemic lupus erythematosus H Kristjansdottir, K Steinsson, I Gunnarsson, G Gröndal, K Erlendsson, ... Arthritis & Rheumatism 62 (6), 1702-1711, 2010 | 79 | 2010 |
| Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus O Ragnarsson, G Gröndal, K Steinsson Lupus 12 (9), 687-691, 2003 | 78 | 2003 |
| Drug-induced autoimmune hepatitis: response to corticosteroids and lack of relapse after cessation of steroids ES Björnsson, O Bergmann, JG Jonasson, G Grondal, B Gudbjornsson, ... Clin Gastroenterol Hepatol 15 (10), 1635-6, 2017 | 76 | 2017 |
| Development of lupus‐related side‐effects in patients with early RA during sulphasalazine treatment—the role of IL‐10 and HLA I Gunnarsson, B Nordmark, A Hassan Bakri, G Gröndal, P Larsson, ... Rheumatology 39 (8), 886-893, 2000 | 73 | 2000 |
| Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus V Magnusson, AKB Lindqvist, C Castillejo-Lopez, H Kristjansdottir, ... Genomics 70 (3), 307-314, 2000 | 65 | 2000 |
| Association of Variants in IL2RA With Progression of Joint Destruction in Rheumatoid Arthritis R Knevel, DPC de Rooy, A Zhernakova, G Gröndal, A Krabben, ... Arthritis & Rheumatism 65 (7), 1684-1693, 2013 | 57 | 2013 |
| Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families G Gröndal, KH Traustadottir, H Kristjansdottir, I Lundberg, L Klareskog, ... Lupus 11 (7), 435-442, 2002 | 55 | 2002 |
| Genetic analysis of the contribution of IL10 to systemic lupus erythematosus. ME Alarcon-Riquelme, AK Lindqvist, I Jonasson, B Johanneson, ... The Journal of Rheumatology 26 (10), 2148-2152, 1999 | 49 | 1999 |
